RGNX · REGENXBIO Inc.
$11.06
-0.96 (-7.99%)
At close · Aug 20
Market Cap
$753.87M
Shares
66.01M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2024-12 | — | $150,000,000 | — | — | 10-Q , filed 2025-08-07 |
Key facts
CIK
1590877
CUSIP
75901B107
13F (30d)
154 filings
154 filers
Visit website
Investor relations